Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BDSX stock hub

Biodesix, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BDSXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

154.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BDSX

In the news

Latest news · BDSX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-316.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-20

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BDSX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001439725
Company name	Biodesix, Inc.
Country	United States
Country code	US
Cusip	09075X207
Employees	334
Employees Change	61%
Employees Change Percent	22.34
Enterprise value	$200.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2020-10-28
Isin	US09075X2071
Last refreshed	2026-05-10
Market cap	$154.8M
Market cap category	Micro-Cap
Price	$15.32
Price currency	USD
Rev Per Employee	287,712.57x
Sector	Healthcare
Sic	8071
Symbol	BDSX
Website	https://www.biodesix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.64%
EV Sales Forward	1.72x
EV/Sales	2.09x
FCF yield	-16.21%
P/B ratio	16.96x
P/S ratio	1.61x
PS Forward	1.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-25.91%
EBITDA Margin	-20.06%
Gross margin	82.08%
Gross Profit	$78.9M
Gross Profit Growth	35.15%
Gross Profit Growth Q	49.77%
Gross Profit Growth3 Y	43.61%
Gross Profit Growth5 Y	20.78%
Net Income	$-32M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	-33.26%
Profit Margin	-33.26%
Profit Per Employee	$-95,680
ROA	-17.21
Roa5y	-25.95
ROCE	-31.07
ROE	-316.5
Roe5y	-320.2
ROIC	-19.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	80.86%
Cagr3y	-22.09%
Cagr5y	-44.27%
EPS Growth Quarters	3
EPS Growth Years	7
Revenue Growth	29.05x
Revenue Growth Q	42.3x
Revenue Growth Quarters	15x
Revenue Growth Years	3x
Revenue Growth3 Y	33.14x
Revenue Growth5 Y	6.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.06
Assets	$94.6M
Cash	$25.6M
Current Assets	$40.9M
Current Liabilities	$14.5M
Debt	$71.6M
Debt Equity	$7.84
Equity	$9.1M
Interest Coverage	-3.11
Liabilities	$85.5M
Long Term Assets	$53.7M
Long Term Liabilities	$71M
Net Cash	$-46M
Net Cash By Market Cap	$-29.73
Net Debt Equity	$5.04
Tangible Book Value	$-9.4M
Tangible Book Value Per Share	$-0.93
WACC	7.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.82
Net Working Capital	$2.3M
Quick ratio	2.42
Working Capital	$26.4M
Working Capital Turnover	$4.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	80.79%
200-day SMA	9.83
3Y total return	-52.72%
50-day SMA	14.43
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.62%
All Time High	639.8
All Time High Change	-97.61%
All Time High Date	2021-01-20
All Time Low	3.44
All Time Low Change	345.87%
All Time Low Date	2025-05-15
ATR	1.31
Beta	0.43
Beta1y	-0.26
Beta2y	0.57
Ch YTD	125.3
High	15.52
High52	20.21
High52 Date	2026-03-12
High52ch	-24.2%
Low	14.79
Low52	3.44
Low52 Date	2025-05-15
Low52ch	345.87%
Ma50ch	6.16%
Premarket Change Percent	-1.75
Premarket Price	$15.2
Premarket Volume	113
Price vs 200-day SMA	55.82%
RSI	63.17
RSI Monthly	44.14
RSI Weekly	59.26
Sharpe ratio	1.05x
Sortino ratio	1.91
Total Return	-14.97%
Tr YTD	125.3
Tr1m	5.44%
Tr1w	38.27%
Tr3m	47.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.13
Earnings Revenue Estimate	23,094,000x
Earnings Revenue Estimate Growth	28.6x
Operating Income	$-24.9M
Operating margin	-25.91
Price target	$33
Price Target Change	$115

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,340,981%
Float Percent	52.84%
Net Borrowing	9,981,000
Shares Insiders	38.72%
Shares Institutions	23.46%
Shares Out	10,107,219
Shares Qo Q	19.73%
Shares Yo Y	14.97%
Short Float	3.26%
Short Ratio	2.55
Short Shares	1.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-29.4M
Average Volume	82,654.6x
Bv Per Share	0.9
CAPEX	$-266,000
Ch1m	5.44
Ch1w	38.27
Ch1y	80.79
Ch3m	47.59
Ch3y	-52.72
Ch5y	-94.62
Ch6m	98.19
Change	-0.97%
Change From Open	-0.97
Close	15.47
Days Gap	0
Depreciation Amortization	5,626,000
Dollar Volume	1,122,148
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-24.9M
EBITDA	$-19.3M
EPS	$-3.93
F Score	4
FCF	$-25.1M
FCF EV Yield	-12.5x
FCF Per Share	$-2.48
Financing CF	33,217,000
Fiscal Year End	December
Founded	2,005
Goodwill	15,031,000
Investing CF	-410,000
Ipr	-14.89
Iprfo	-94.36
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2025-09-15
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	10.4
Ma150ch	47.38%
Ma20	12.34
Ma20ch	24.16%
Net CF	7,970,000
Next Earnings Date	2026-08-06
Open	15.47
Optionable	Yes
Position In Range	72.6
Post Close	15.32
Postmarket Change Percent	-1.37
Postmarket Price	$15.11
Ppne	27,380,000
Pre Close	15.47
Price Date	2026-05-08
Relative Volume	0.89x
Revenue	96,096,000x
SBC By Revenue	4.46x
Share Based Comp	4,282,000
Tr6m	98.19%
Us State	Colorado
Volume	73,247.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BDSX pay a dividend?

Capital-return profile for this ticker.

Performance

BDSX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BDSX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.5%

Float: +52.8% of shares outstanding

Insider ownership

+38.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BDSX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.2

Neutral momentum band

Price vs 200-day MA

+55.8%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BDSX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BDSX stock rating?

Biodesix, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BDSX analysis?

The full report lives at /stocks/BDSX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BDSX?

The latest report frames BDSX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BDSX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.